Regenxbio RGNX
NASDAQ RGNX
$8.47 +0.78 (+10.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Regenxbio (RGNX) Price to Earnings (2018 - 2022)

Updated

Regenxbio's Price to Earnings was 15.54 in Q3 2022, up 32.2% from the prior quarter.

Analysis

Regenxbio (RGNX) Price to Earnings (2018 - 2022) Analysis & Trends

For FY2021, Price to Earnings at Regenxbio came in at 10.96.

  • In earlier years, Price to Earnings was 15.16 in FY2018.
  • The Q3 2022 figure marks the highest quarterly Price to Earnings since Q3 2018.
  • Per Business Quant data, RGNX's Price to Earnings in the three quarters before Q3 2022 was 11.75 (Q2 2022), 14.09 (Q1 2022) and 10.96 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Regenxbio 508.48 Mn -228.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 15.54
Jun 30, 2022 11.75
Mar 31, 2022 14.09
Dec 31, 2021 10.96
Dec 31, 2018 15.16
Sep 30, 2018 33.85
Jun 30, 2018 29.64
Mar 31, 2018 17.94
API Access

Regenxbio Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=RGNX&period=max&api_key=YOUR_API_KEY